Complex analysis of cyclin D1 expression in mantle cell lymphoma: two cyclin D1-negative cases detected

Warning

This publication doesn't include Faculty of Medicine. It includes Faculty of Science. Official publication website can be found on muni.cz.

Authors	ŠTEFANČÍKOVÁ Lenka MOULIS Mojmír FABIAN P. FALKOVA I. VASOVA I. KREN L. MACAK J. ŠMARDOVÁ Jana
Year of publication	2009
Type	Article in Periodical
Magazine / Source	American journal of clinical pathology : official publication the American Society of Clinical Pathologists.
MU Faculty or unit	Faculty of Science
Citation
Web	https://jcp.bmj.com/content/jclinpath/62/10/948.full.pdf
Doi	http://dx.doi.org/10.1136/jcp.2008.063701
Keywords	GENE; OVEREXPRESSION; CCND2
Description	Background and Aim: The cytogenetic and diagnostic hallmark of mantle cell lymphoma (MCL) is translocation t(11; 14)(q13; q32), resulting in overexpression of cyclin D1. Cyclin D1 expression was analysed in 32 cases of MCL. Methods: The t(11; 14) translocation was detected by fluorescence in situ hybridisation, level of cyclin D1 mRNA by competitive RT-PCR, and level of cyclin D1 and D2 proteins by immunohistochemistry and/or immunoblotting. Results: In 30 cases, the presence of translocation t(11; 14), a high level of cyclin D1 mRNA, and a high level of the cyclin D1 protein were confirmed. Two cyclin D1-negative cases overexpressing cyclin D2 were detected by immunoblotting. Conclusions: There are rare cyclin D1-negative cases of MCL overexpressing cyclin D2. Anti-cyclin D1 antibodies with low specificity can bind both cyclin D1 and cyclin D2, thus providing false cyclin D1-positive signals in immunohistochemical analysis.
Related projects:	Molecular basis of cell and tissue regulations Molecular mechanisms of the cell proliferation and differentiation